You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

EUTHYROX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Euthyrox patents expire, and when can generic versions of Euthyrox launch?

Euthyrox is a drug marketed by Provell and is included in one NDA.

The generic ingredient in EUTHYROX is levothyroxine sodium. There are ten drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Euthyrox

A generic version of EUTHYROX was approved as levothyroxine sodium by MYLAN on June 5th, 2002.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for EUTHYROX?
  • What are the global sales for EUTHYROX?
  • What is Average Wholesale Price for EUTHYROX?
Summary for EUTHYROX
Drug patent expirations by year for EUTHYROX
Drug Prices for EUTHYROX

See drug prices for EUTHYROX

Recent Clinical Trials for EUTHYROX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyPhase 1
First People's Hospital of HangzhouPhase 4
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 4

See all EUTHYROX clinical trials

Pharmacology for EUTHYROX
Drug Classl-Thyroxine

US Patents and Regulatory Information for EUTHYROX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Provell EUTHYROX levothyroxine sodium TABLET;ORAL 021292-001 May 31, 2002 AB2 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Provell EUTHYROX levothyroxine sodium TABLET;ORAL 021292-007 May 31, 2002 AB2 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Provell EUTHYROX levothyroxine sodium TABLET;ORAL 021292-004 May 31, 2002 AB2 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.